Insider trade

Director received an award of 105K GDRX derivative securities

Traded Nov 2, 2025 · Filed Nov 4, 2025

Goodrx HoldingsGDRX

105K
Derivative units

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Nov 2, 2025
Reporting period: Not applicable
Filed with the SEC: Nov 4, 2025

DirectorGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001809519-25-000138
Filed / recorded

Nov 4, 2025, 12:59 AM UTC

Added to OQRO

Oct 7, 2026, 5:51 AM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

GoodRx Holdings, Inc.

Issuer CIK

1809519

Ticker

GDRX

Reporting person

Trevor Bezdek

Relationship

Director

Security

Restricted Stock Unit

Table

Derivative (Table II)

Transaction date

Nov 2, 2025

Transaction code

A

Shares / units

104,925

Price per share

$0.00

Acquired / disposed

Acquired (A)

Shares owned after

104,925

Ownership form

Direct

Amendment

No

Footnotes from the filing

Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
The restricted stock unit award vests as to one-third of the shares underlying the award on each of the first three anniversaries of the grant date, beginning on November 2, 2026, subject to continued service through the applicable vesting date.